Induction infliximab levels among patients with acute severe ulcerative colitis compared with patients with moderately severe ulcerative colitis

B. Ungar*, Y. Mazor, R. Weisshof, H. Yanai, Y. Ron, I. Goren, A. Waizbard, M. Yavzori, E. Fudim, O. Picard, R. Loebstein, U. Kopylov, I. Dotan, Y. Chowers, R. Eliakim, S. Ben-Horin

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

72 Scopus citations

Fingerprint

Dive into the research topics of 'Induction infliximab levels among patients with acute severe ulcerative colitis compared with patients with moderately severe ulcerative colitis'. Together they form a unique fingerprint.

Medicine & Life Sciences